Modernizing pharmaceutical manufacturing is seen as offering a solution to drug shortages and vulnerabilities of drug supply chains, but there are technical, regulatory, and other barriers to doing so. The virtual workshop Barriers to Innovations in Pharmaceutical Manufacturing held on June 2-3, 2020, provided a venue for discussing barriers to innovations in the pharmaceutical industry and included sessions on integration, intensification, and control; innovative processing technologies; and disruptive technologies and convergent innovations. It was hosted by the National Academies of Sciences, Engineering, and Medicine Committee to Identify Innovative Technologies to Advance Pharmaceutical Manufacturing and served as the second information-gathering activity to assist the committee with producing its consensus report. This Proceedings of a Workshop-in Brief summarizes the presentations and discussions that took place during the workshop.
Table of Contents
|Barriers to Innovations in Pharmaceutical Manufacturing: Proceedings of a Workshop - in Brief||1-12|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Barriers to Innovations in Pharmaceutical Manufacturing: Proceedings of a Workshop–in Brief...